In addition, different studies reveal that LCN2 levels are significantly increased in patients with CAD and correlate with disease severity [37] and myocardial infarction [38] and therefore might serve as a potential biomarker for cardiovascular events. The gene discussed is LCN2; the disease is myocardial infarction.